13 October, 2026 | Tuesday | News

Agreement is expected to grant Theramex exclusive rights to CEVIRA® in Europe, Australia, New Zealand and Turkey, while Asieris retains rights for the rest of the world. The deal includes 15 million US d...

14 October, 2026 | Wednesday | News

CellCarta, a leading global CRO laboratory to the biopharmaceutical industry,  announced a strategic partnership with Waters Corporation, a global leader in life sciences and diagnostics, creating a framew...

14 October, 2026 | Wednesday | News

Wuhan Hiteck Biological Pharma Co., Ltd.  announced that it has entered into an exclusive license agreement (the "License Agreement") with Visara, Inc. ("Visara"), a majority-owned ophthalmology subsidiary...

14 October, 2026 | Wednesday | News

  The new 360biolabs facility in North Ryde is strategically located within one of Sydney’s vibrant science and medtech hubs, Macquarie Park Innovation District alongside a growing community of inno...

14 October, 2026 | Wednesday | News

- Rona Therapeutics announced it has granted Roche an exclusive worldwide license for Rona's investigational RNAi candidate targeting activin receptor-like kinase 7 (ALK7) utilizing the company's proprietary ex...

12 October, 2026 | Monday | News

Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (...

13 October, 2026 | Tuesday | News

 Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, announced that the first patient has...